Guideline Summary for Management of Herpes Labialis (Cold Sores)

1. Episodic Oral Antiviral Therapy

For immunocompetent adults with an active outbreak, short‑course oral antivirals accelerate healing and reduce pain.

2. Timing of Treatment Initiation

Early therapy is critical for maximal benefit.

3. Topical Antiviral Agents (Second‑Line)

Reserved for patients who cannot take oral medication.

4. Chronic Suppressive Therapy for Frequent Recurrences

Indicated for patients with ≥ 6 episodes per year.

5. Non‑Pharmacologic Prophylaxis for Trigger‑Related Outbreaks

Simple measures can lessen UV‑induced recurrences.

6. Special Populations & Considerations

7. Common Pitfalls to Avoid

All statements are derived from peer‑reviewed randomized controlled trials and systematic reviews cited above.

Evidence‑Based Management of Herpes Labialis

Oral Antiviral Therapy for Acute Episodes

• Acyclovir 400 mg taken five times daily for 5 days shortens episode duration by approximately 1 day compared with placebo (randomized trial) 9
• Valacyclovir 2 g twice daily (single‑day) and famciclovir 1500 mg single dose provide comparable efficacy to acyclovir but offer superior convenience because they require only one day of dosing (clinical trial) 9
• Clinicians should preferentially prescribe single‑day valacyclovir or famciclovir rather than five‑times‑daily acyclovir, since efficacy is equivalent and adherence is markedly better (expert recommendation based on trial data) 9

Limitations of Topical Antivirals

• Topical agents such as penciclovir 1 % cream or acyclovir 5 % cream do not prevent recurrences because they cannot reach the sensory ganglia where HSV‑1 latency resides (virological evidence) 10
• Acyclovir/hydrocortisone combination cream applied 5–6 times daily reduces both ulcerative and non‑ulcerative recurrences, but its benefit is modest and it still cannot serve as prophylaxis (clinical trial) 9

Dosing Recommendations to Optimize Outcomes

• Initiate oral antiviral therapy within 24–48 hours of prodromal symptoms to target peak viral replication and achieve maximal reduction in healing time (guideline principle) 9

Alternative/Complementary Therapies

• Topical herbal preparations (e.g., lemon balm, olive leaf extract, propolis, sage‑rhubarb) have shown potential benefit in small trials but the evidence remains limited compared with standard oral antivirals (preliminary data) 9

Evidence‑Based Recommendations for Herpes Labialis Management

First‑Line Oral Antiviral Therapy

Topical Antiviral Use

Non‑Pharmacologic Prophylaxis

Alternative and Complementary Therapies